Jeroen van Dorp (Jeroen Van Dorp)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Muscle Invasive Bladder Cancer

Circulating Tumor

Top Venues

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, Iris M Seignette, Jan-Jaap J Mellema, Maartje Alkemade, Alberto Gil-Jimenez, Dennis Peters, Wim Brugman, Chantal F Stockem, Erik Hooijberg, Annegien Broeks, Bas W G van Rhijn, Laura S Mertens, Antoine G Van der Heijden, Niven Mehra, Maurits L van Montfoort, Lodewyk F A Wessels, Daniel J Vis, Michiel S Van Der Heijden
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L van Montfoort, Sophie Hackinger, Linde M Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W van de Kamp, Kees Hendricksen, Jeantine M de Feijter, Thierry N Boellaard, Richard P Meijer, Antoine G van der Heijden, Nitzan Rosenfeld, Bas W G van Rhijn, Greg Jones, Michiel S Van Der Heijden
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature medicine (2023)
Jeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L van Montfoort, Sophie Hackinger, Linde M Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W van de Kamp, Kees Hendricksen, Jeantine M de Feijter, Thierry N Boellaard, Richard P Meijer, Toine G van der Heijden, Nitzan Rosenfeld, Bas W G van Rhijn, Greg Jones, Michiel S Van Der Heijden
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature medicine 29 (3) (2023)
Jeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L van Montfoort, Sophie Hackinger, Linde M Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W van de Kamp, Kees Hendricksen, Jeantine M de Feijter, Thierry N Boellaard, Richard P Meijer, Toine G van der Heijden, Nitzan Rosenfeld, Bas W G van Rhijn, Greg Jones, Michiel S Van Der Heijden
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature medicine 29 (3) (2023)
Jeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L van Montfoort, Sophie Hackinger, Linde M Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W van de Kamp, Kees Hendricksen, Jeantine M de Feijter, Thierry N Boellaard, Richard P Meijer, Toine G van der Heijden, Nitzan Rosenfeld, Bas W G van Rhijn, Greg Jones, Michiel S Van Der Heijden
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature medicine (2023)
Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, Isabelle Peguillet, Marianne Gazzano, Maxime Descartes Mbogning Fonkou, Cassandra Thelemaque, Cedric Lebacle, Constance Thibault, Francois Audenet, Géraldine Pignot, Gwenaëlle Gravis, Carole Helissey, Luca Campedel, Morgan Roupret, Evanguelos Xylinas, Idir Ouzaid, Agathe Dubuisson, Marine Mazzenga, Caroline Flament, Pierre Ly, Virginie Marty, Nicolas Signolle, Allan Sauvat, Thomas Sbarrato, Mounia Filahi, Caroline Davin, Gabriel Haddad, Jacques Yb Khalil, Camille Blériot, François-Xavier Danlos, Garett Dunsmore, Kevin Mulder, Aymeric Silvin, Thibault Raoult, Baptiste Archambaud, Shaima Belhechmi, Ivo Gomperts Boneca, Nadège Cayet, Maryse Moya-Nilges, Adeline Mallet, Romain Daillère, Etienne Rouleau, Camelia Radulescu, Yves Allory, Jacques Fieschi, Mathieu Rouanne, Florent Ginhoux, Gwénaël Le Teuff, Lisa Derosa, Aurélien Marabelle, Jeroen van Dorp, Nick van Dijk, Michiel S Van Der Heijden, Benjamin Besse, Fabrice Andre, Miriam Merad, Guido Kroemer, Jean Yves Scoazec, Laurence Zitvogel, Yohann Loriot
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer. Cancer discovery 12 (10) (2022)